These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7872247)

  • 1. Activated protein C resistance and inherited thrombosis.
    Rodgers GM
    Am J Clin Pathol; 1995 Mar; 103(3):261-2. PubMed ID: 7872247
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to activated protein C due to factor V R506Q mutation as a cause of venous thrombosis.
    Dahlbäck B
    Rev Invest Clin; 1997 May; 49 Suppl 1():3-5. PubMed ID: 9291738
    [No Abstract]   [Full Text] [Related]  

  • 3. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of lupus anticoagulant on a commercially available kit for APC-resistance.
    Halbmayer WM; Haushofer A; Schön R; Fischer M
    Thromb Haemost; 1994 Oct; 72(4):645-6. PubMed ID: 7878647
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.
    Dahlbäck B
    Thromb Haemost; 1995 May; 73(5):739-42. PubMed ID: 7482395
    [No Abstract]   [Full Text] [Related]  

  • 6. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis.
    Bertina RM; Reitsma PH; Rosendaal FR; Vandenbroucke JP
    Thromb Haemost; 1995 Jul; 74(1):449-53. PubMed ID: 8578504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg-->Gln mutation in the gene for factor V.
    Greengard JS; Eichinger S; Griffin JH; Bauer KA
    N Engl J Med; 1994 Dec; 331(23):1559-62. PubMed ID: 7969326
    [No Abstract]   [Full Text] [Related]  

  • 8. Inherited resistance to activated protein C, a major basis of venous thrombosis, is caused by deficient anticoagulant cofactor function of factor V.
    Dahlbäck B
    Haematologica; 1995; 80(2 Suppl):102-13. PubMed ID: 7628762
    [No Abstract]   [Full Text] [Related]  

  • 9. [Activated protein C resistance as a cause of thrombophilia].
    Ruiz-Argüelles GJ
    Rev Invest Clin; 1996; 48(3):223-9. PubMed ID: 8966383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V; Leone G
    Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Resistance to activated protein C--a novel cause of thrombophilia].
    Cycowitz Z; Seligsohn U; Zivelin A; Eldor A
    Harefuah; 1995 Jul; 129(1-2):1-5, 80. PubMed ID: 7557699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R; Ens GE
    Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene.
    Dahlbäck B
    Haemostasis; 1994; 24(2):139-51. PubMed ID: 7959362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to activated protein C in thalassaemic patients: an underlying cause of thrombosis.
    Giordano P; Del Vecchio GC; Altomare M; Coppola B; Schettini F; Iolascon A; De Mattia D
    Eur J Haematol; 1998 Aug; 61(2):123-7. PubMed ID: 9714525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor V Leiden and thrombophilia.
    Simioni P; Scudeller A; Girolami A
    N Engl J Med; 1995 May; 332(20):1382. PubMed ID: 7715653
    [No Abstract]   [Full Text] [Related]  

  • 17. A more discriminating test for APC resistance and a possible screening test to include protein C and protein S.
    Denson KW; Haddon ME; Reed SV; Davidson S; Littlewood TJ
    Thromb Res; 1996 Jan; 81(1):151-6. PubMed ID: 8747530
    [No Abstract]   [Full Text] [Related]  

  • 18. Modified test for activated protein C resistance.
    Jorquera JI; Montoro JM; Fernández MA; Aznar JA; Aznar J
    Lancet; 1994 Oct; 344(8930):1162-3. PubMed ID: 7864945
    [No Abstract]   [Full Text] [Related]  

  • 19. High prevalence of the FVR506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis.
    Zöller B; Norlund L; Leksell H; Nilsson JE; von Schenck H; Rosén U; Jepsson JO; Dahlbäck B
    Thromb Res; 1996 Sep; 83(6):475-7. PubMed ID: 8885142
    [No Abstract]   [Full Text] [Related]  

  • 20. [Activated protein C resistance in the Japanese].
    Ozawa T
    Rinsho Ketsueki; 1996 Sep; 37(9):790-3. PubMed ID: 8914464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.